ACTRON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actron, and what generic alternatives are available?
Actron is a drug marketed by Bayer and is included in one NDA.
The generic ingredient in ACTRON is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Actron
A generic version of ACTRON was approved as ketoprofen by TEVA on December 22nd, 1992.
Summary for ACTRON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 166 |
Patent Applications: | 4,821 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ACTRON at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ACTRON
US Patents and Regulatory Information for ACTRON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer | ACTRON | ketoprofen | TABLET;ORAL | 020499-001 | Oct 6, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |